| Applicable Product Standard | ISO 8537 | Sterile, single-use syringes with or without needles specifically intended for insulin administration. | Request a valid declaration of conformity, test report, and product specification covering the applicable ISO 8537 requirements. |
| Insulin Concentration | U-100 = 100 units/mL | One insulin unit corresponds to 0.01 mL when the insulin concentration is U-100. | The syringe barrel and graduation must be clearly marked for U-100 insulin. Do not use a U-100 scale for a different insulin concentration. |
| Common Nominal Capacities | 0.3 mL / 30 units 0.5 mL / 50 units 1.0 mL / 100 units | These capacities cover commonly required U-100 insulin dose ranges. | Confirm the nominal capacity, maximum unit marking, dead space, and compatibility with the intended dosing range. |
| Graduation Scale | Must correspond to the stated insulin concentration and nominal capacity. | The scale should allow the intended dose to be read directly in insulin units without an additional volume conversion. | Check graduation spacing, numeral visibility, line thickness, zero position, and readability after sterilization and packaging. |
| Typical Graduation Options | 1-unit markings are commonly used on 0.3 mL and 0.5 mL syringes. 2-unit markings are commonly used on many 1.0 mL syringes. | Actual graduation intervals vary by product design and intended dose accuracy. | Approve the exact artwork and sample before production; do not rely only on nominal capacity. |
| Needle Gauge | Common insulin-syringe configurations include approximately 29G to 31G. | A higher gauge number generally indicates a smaller outside needle diameter. Needle gauge is not determined by U-100 concentration. | Specify gauge, outside diameter, wall type, needle sharpness, and penetration performance in the technical agreement. |
| Needle Length | Common configurations include approximately 6 mm to 13 mm. | Needle length should match the intended patient population, injection technique, and clinical application. | Verify needle length, exposed length, hub security, protective cap fit, and user instructions. |
| Needle Attachment | Fixed needle or other configuration specified by the product design. | A fixed-needle design can reduce medication residual volume compared with some detachable-needle designs. | Confirm the needle-to-syringe connection, leakage resistance, pull-off force, and dead-space specification. |
| Sterility | Sterile and single-use | The device must be supplied sterile and protected from contamination until the sterile barrier is opened. | Review sterilization validation, sterility test records, residual limits where applicable, and package integrity data. |
| Sterilization Method | Ethylene oxide or radiation may be used, depending on the validated product process. | The sterilization method must be compatible with the materials, packaging, needle lubricant, and product performance. | Request sterilization-cycle validation and routine release documentation. For ethylene oxide, verify residual control. |
| Barrel and Plunger Materials | Medical-grade polymer components are commonly used; the exact material must be declared by the supplier. | Materials should maintain dimensional stability, transparency, compatibility, and mechanical performance throughout shelf life. | Request material specifications, biocompatibility evidence, extractables information where required, and change-control commitments. |
| Dose Accuracy | Performance must be assessed against the applicable ISO 8537 requirements for the specified syringe capacity and scale. | The delivered dose should remain within the applicable tolerance when the syringe is filled and operated as instructed. | Review capacity-specific accuracy test results, sampling plans, test methods, and acceptance criteria. |
| Leakage and Plunger Movement | Barrel, plunger, and needle assembly must maintain functional integrity during use. | The syringe should not leak, separate, or require excessive force during filling and injection. | Check leakage, plunger force, stopper movement, flange strength, and needle-hub security using production samples. |
| Lubrication | Lubrication may be used to support smooth plunger movement, subject to product and regulatory requirements. | Excessive or incompatible lubricant can affect dose delivery, packaging, or biocompatibility. | Verify lubricant type, quantity control, compatibility, and relevant safety documentation. |
| Packaging | Each syringe should be protected by an appropriate sterile barrier system. | Packaging must preserve sterility and protect the needle, barrel, graduation scale, and plunger during transport and storage. | Review seal strength, package integrity, transport simulation, shelf-life studies, and storage conditions. |
| Labeling | Product labeling should identify the nominal capacity, insulin-unit scale, sterility status, single-use status, and applicable warnings. | Clear labeling helps prevent dose-selection errors and improper reuse. | Approve labels, carton artwork, instructions for use, lot identification, manufacturing date, expiry date, and traceability information. |
| U-100 Compatibility Warning | Use only with U-100 insulin when the syringe is marked U-100. | Using a syringe calibrated for one insulin concentration with another concentration can result in a significant dosing error. | Include a clear concentration warning in the labeling and verify that the scale cannot be mistaken for a volume-only scale. |
| Quality-System Evidence | Medical-device quality controls should support consistent production and traceability. | Process control is essential for graduation accuracy, needle quality, sterility, packaging, and lot-to-lot consistency. | Evaluate the supplier’s quality-system certification, audit history, complaint handling, CAPA process, and change notification procedure. |